Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,672 public trials 1,509 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Active, Not Recruiting

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

NCT03526432

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • UAB Women and Infants Center Birmingham, Alabama, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

NCT02912572

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

NCT06182241

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Cancer, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
  • MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand Durban, KwaZulu-Natal, South Africa
View Trial Details
Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

NCT02264678

Conditions
Adnexal Diseases, Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 28 locations
View Trial Details

Related conditions